Among patients receiving beta‐blockers, those receiving higher doses tended to be younger, obese, less likely to being hospitalized in the last 12 months, with a more frequent history of ventricular arrhythmias and lower values of NT‐proBNP (online supplementary Table S1). The gene discussed is NPPB; the disease is Ventricular arrhythmia.